Kenneth Mahaffey
Associate Dean, Clinical Research · Stanford University
Credentials: · · · · ·
History
2013–PresentClinical Research · Stanford University
- Present
Clinical Research · Stanford University
- 2013–Present
Until 1996- Until 1993
- Until 1993
Chief Resident
Research
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
New England Journal of Medicine · 2011 · 7,354 citations
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
New England Journal of Medicine · 2017 · 5,868 citations
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
New England Journal of Medicine · 2009 · 5,587 citations
149 papers
133 papers
113 papers · 20 as a fellow
99 papers
90 papers
- DS
80 papers
Peter Kowey
79 papers
78 papers
Grants
- 2020–2027
The LIMIting AAA with meTformin (LIMIT) Trial
National Heart, Lung, and Blood Institute · R33
PI · $6.4M · Stanford University
- 2019–2026
1/1: Arrest Respiratory Failure Due to Pneumonia (Arrest Pneumonia)
National Heart, Lung, and Blood Institute · UH3
PI · $7.8M · Stanford University
- 2020–2022
The LIMIting AAA with meTformin (LIMIT) Trial
National Heart, Lung, and Blood Institute · R61
PI · $1.5M · Stanford University
- 2019–2020
1/1: Arrest Respiratory Failure Due to Pneumonia (Arrest Pneumonia)
National Heart, Lung, and Blood Institute · UG3
PI · $1.4M · Stanford University
Clinical trials
- 2015–2017
Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
Principal investigator · Completed · Phase 2
Ken Mahaffey